Thursday, 8th of August 2013 |
+ Author Affiliations
1. 1Medical Research Council Clinical Trials Unit, London, UK 2. 2Division of Infection and Immunity, University College London, London, UK 3. 3Virus Reference Department, Health Protection Agency, London, UK 4. 4Directorate of HIV Medicine and Sexual Health, Chelsea and Westminster Hospital, London, UK 5. 5Research Department of Infection and Population Health, University College London, London, UKJ Infect Dis. (2013) doi: 10.1093/infdis/jit345 First published online: July 31, 2013
Abstract below; full text is at http://jid.oxfordjournals.org/content/early/2013/07/31/infdis.jit345.full.pdf+html
There are few data on the persistence of individual transmitted HIV-1 drug resistance (TDR) mutations in the absence of selective drug pressure. We studied 313 patients in whom TDR mutations were detected at their first resistance test and who had a subsequent test performed whilst ART-naive. The rate at which mutations became undetectable was estimated using exponential regression accounting for interval censoring. Most thymidine analogue mutations (TAMs) and T215 revertants (but not T215F/Y) were found to be highly stable, with NNRTI and PI mutations being relatively less persistent. Our estimates are important for informing HIV transmission models.
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41196632 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |